$ICE

Martin Lynn C sold $2.2M of ICE

Martin Lynn C (President, NYSE Group) sold 15,882 shares of Intercontinental Exchange, Inc. (ICE) at an average of $141.15 ($139.75–$142.30, $2.24M total) across 4 trades on 2026-07-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Martin Lynn C
Published Jul 20, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 20, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ICE
Neutral
high confidence
Mentioned
$ICE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ICENeutralLow
01

Why it matters

The only new fact is the disclosed sale size, price range, and that it was executed under a pre-arranged 10b5-1 plan; it does not introduce new company fundamentals.

02

Market read

Traders may note the insider sale for positioning, but the 10b5-1 structure reduces interpretive weight.

03

What to watch

The article provides no context on total holdings, option exercises, or whether other insiders are buying, so the signal is incomplete.

Relevance 5/10Novelty 3/10Timing: Filed on 2026-07-20, covering sales executed on 2026-07-16.

Background

The article is an SEC Form 4 insider transaction disclosure for Intercontinental Exchange, Inc.

Company-level read

Ticker impact

$ICENeutralHigh confidence
Context

Intercontinental Exchange Form 4 shows President of NYSE Group Martin Lynn C sold 15,882 shares for about $2.24M under a 10b5-1 plan.

Expected impact

Likely minimal immediate impact; any effect is more about liquidity/positioning than company-specific news.

Evidence & confidence

The filing is a routine insider transaction with explicit 10b5-1 pre-arrangement, and it does not disclose new operating, regulatory, or financial information.

Market effects

No clear sector read-through; this is company-specific insider trading without new guidance or events.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with personal diversification needs, which some traders may still treat as a mild sentiment headwind.

Key entities

  • Intercontinental Exchange, Inc.

    NYSE Group-related insider transaction disclosed via SEC Form 4.

  • Martin Lynn C

    President, NYSE Group, who sold 15,882 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MKTXHighAI 9/10

MarketAxess Holdings Inc. entered into an Agreement and Plan of Merger with Intercontinental Exchange, Inc. and Igloo Merger Sub II, Inc., providing for the…

MARKETAXESS HOLDINGS INC (MKTX) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. As previously disclosed, on July 29, 2026, MarketAxess Holdings Inc. (“ MarketAxess ”) entered into an Agreement and Plan of Merger with Intercontinental Exchange, Inc. (“ Parent ”) and Igloo Merger Sub II, Inc. (“ Merger Sub ”), providing for the merger

$ICEMed

NYSE Owner Challenges CME in Livestock Futures Market

Intercontinental Exchange (NYSE owner) plans to launch cattle and hog futures contracts by December 7, pending approval, challenging CME Group. It will offer physically settled cattle futures and three cash-settled contracts. CME is updating its trading infrastructure, with some traders concerned about costs and speeds.

$ICEMed

ICE to launch cattle and hog futures in challenge to CME

Intercontinental Exchange (ICE) plans to launch cattle and hog futures contracts on December 7, pending regulatory approval. ICE aims to compete with CME Group, offering physically delivered US live cattle futures and financially settled futures for live cattle, feeder cattle, and lean hogs. CME recently canceled plans to temporarily relocate livestock markets to Dallas, citing faster progress on cloud migration.

$ICEMed

Intercontinental Exchange stock price target maintained at $170 by KBW

Keefe Bruyette & Woods maintained an Outperform rating and $170 price target for Intercontinental Exchange (NYSE: ICE), citing strong long-term energy outlook and data center growth. ICE reported Q2 adjusted EPS of $1.90, revenue of $2.67B, and record recurring revenue of $1.4B. The company announced a $5.7B deal to acquire MarketAxess Holdings and introduced precious metals futures in London.